Dhawal Chobisa1,2, Anbukkarasi Muniyandi3, Kamakshi Sishtla3

  • 1Department of Industrial and Molecular Pharmaceutics, Purdue University, 575 West Stadium Avenue, West Lafayette, IN, 47907, USA.

概括

一种新的灰色富尔 (GRF) 微粒疗法显示出治疗新血管与年龄相关的黄斑变性 (nAMD) 的前景. 这种持续的眼部药物递送在临床前模型中有效抑制胆道新血管化 (CNV).